 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Dehydrogenase
|
PDB id
|
|
|
|
1fdw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.1.1.62
- Estradiol 17-beta-dehydrogenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Estradiol-17-beta + NAD(P)(+) = estrone + NAD(P)H
|
 |
 |
 |
 |
 |
Estradiol-17-beta
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
NAD(P)(+)
|
=
|
estrone
|
+
|
NAD(P)H
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
2 terms
|
 |
|
Biological process
|
metabolic process
|
7 terms
|
 |
|
Biochemical function
|
catalytic activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
273:8145-8152
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase.
|
|
C.Mazza,
R.Breton,
D.Housset,
J.C.Fontecilla-Camps.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Type 1 17beta-hydroxysteroid dehydrogenase (17beta-HSD1), a member of the short
chain dehydrogenase reductase (SDR) family, is responsible for the synthesis of
17beta-estradiol, the biologically active estrogen involved in the genesis and
development of human breast cancers. Here, we report the crystal structures of
the H221L 17beta-HSD1 mutant complexed to NADP+ and estradiol and the H221L
mutant/NAD+ and a H221Q mutant/estradiol complexes. These structures provide a
complete picture of the NADP+-enzyme interactions involving the flexible 191-199
loop (well ordered in the H221L mutant) and suggest that the hydrophobic
residues Phe192-Met193 could facilitate hydride transfer. 17beta-HSD1 appears to
be unique among the members of the SDR protein family in that one of the two
basic residues involved in the charge compensation of the 2'-phosphate does not
belong to the Rossmann-fold motif. The remarkable stabilization of the NADP+
2'-phosphate by the enzyme also clearly establishes its preference for this
cofactor relative to NAD+. Analysis of the catalytic properties of, and
estradiol binding to, the two mutants suggests that the His221-steroid O3
hydrogen bond plays an important role in substrate specificity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Superposition of the 187-209 loop of the
wild-type 17 -HSD1 model
(1bhs (24)) (medium gray) and the monomer mC of the
H221L·E2·NAD^+ complex (black) with the 182-203
loop of the MLCR model (1cyd (22)) (light gray). Phe^192 of the
H221L mutant and Met186 of MLCR superpose very well and make
extensive hydrophobic contacts with the nicotinamide ring.
Lys195 of the H221L model interacts with the 2'-phosphate while
no equivalent residue is found for MLCR.
|
 |
Figure 6.
Fig. 6. Stereoscopic view of the steroid binding site of
wild-type (1fdt model in yellow, and 1fds model in orange),
H221L (monomers mC in blue, mD in light blue), and H221Q (pink).
Phe^226 of the 1fdt model and Gln221 of the H221Q mutant are
shown with their two modeled conformations. The steroid
environment is very well conserved, especially Phe^155 and
Ser142 which are the residues involved in the catalytic
reaction. Significant deviations are observed for the steroid,
especially for its C and D rings.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1998,
273,
8145-8152)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Oster,
T.Klein,
C.Henn,
R.Werth,
S.Marchais-Oberwinkler,
M.Frotscher,
and
R.W.Hartmann
(2011).
Bicyclic Substituted Hydroxyphenylmethanone Type Inhibitors of 17 β-Hydroxysteroid Dehydrogenase Type 1 (17 β-HSD1): The Role of the Bicyclic Moiety.
|
| |
ChemMedChem, 6,
476-487.
|
 |
|
|
|
|
 |
M.Negri,
M.Recanatini,
and
R.W.Hartmann
(2010).
Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation.
|
| |
PLoS One, 5,
e12026.
|
 |
|
|
|
|
 |
M.Mazumdar,
D.Fournier,
D.W.Zhu,
C.Cadot,
D.Poirier,
and
S.X.Lin
(2009).
Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy.
|
| |
Biochem J, 424,
357-366.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Machielsen,
N.G.Leferink,
A.Hendriks,
S.J.Brouns,
H.G.Hennemann,
T.Dauβmann,
and
J.van der Oost
(2008).
Laboratory evolution of Pyrococcus furiosus alcohol dehydrogenase to improve the production of (2S,5S)-hexanediol at moderate temperatures.
|
| |
Extremophiles, 12,
587-594.
|
 |
|
|
|
|
 |
R.Zhang,
G.Zhu,
W.Zhang,
S.Cao,
X.Ou,
X.Li,
M.Bartlam,
Y.Xu,
X.C.Zhang,
and
Z.Rao
(2008).
Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity.
|
| |
Protein Sci, 17,
1412-1423.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.S.Paithankar,
C.Feller,
E.B.Kuettner,
A.Keim,
M.Grunow,
and
N.Sträter
(2007).
Cosubstrate-induced dynamics of D-3-hydroxybutyrate dehydrogenase from Pseudomonas putida.
|
| |
FEBS J, 274,
5767-5779.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.H.Ehrensberger,
R.A.Elling,
and
D.K.Wilson
(2006).
Structure-guided engineering of xylitol dehydrogenase cosubstrate specificity.
|
| |
Structure, 14,
567-575.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.K.Yang,
M.S.Park,
G.S.Waldo,
and
S.W.Suh
(2003).
Directed evolution approach to a structural genomics project: Rv2002 from Mycobacterium tuberculosis.
|
| |
Proc Natl Acad Sci U S A, 100,
455-460.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Ghosh,
and
P.Vihko
(2001).
Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1.
|
| |
Chem Biol Interact, 130,
637-650.
|
 |
|
|
|
|
 |
B.S.Zhorov,
and
S.X.Lin
(2000).
Monte Carlo-minimized energy profile of estradiol in the ligand-binding tunnel of 17 beta-hydroxysteroid dehydrogenase: atomic mechanisms of steroid recognition.
|
| |
Proteins, 38,
414-427.
|
 |
|
|
|
|
 |
D.G.Gourley,
J.Luba,
L.W.Hardy,
S.M.Beverley,
and
W.N.Hunter
(1999).
Crystallization of recombinant Leishmania major pteridine reductase 1 (PTR1).
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1608-1610.
|
 |
|
|
|
|
 |
M.W.Sawicki,
M.Erman,
T.Puranen,
P.Vihko,
and
D.Ghosh
(1999).
Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
|
| |
Proc Natl Acad Sci U S A, 96,
840-845.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|